Johnson & Johnson Settles Risperdal Claim in Texas
Thursday, January 19, 2012 - 22:50
in Psychology & Sociology
Johnson & Johnson said it would pay $158 million to end a lawsuit that accused it of inappropriately marketing its Risperdal antipsychotic drug to Texas residents on Medicaid.